Colgate-Palmolive Company (NYSE:CL)‘s stock had its “hold” rating reiterated by investment analysts at Jefferies Group LLC in a report released on Monday, July 24th. They presently have a $79.00 target price on the stock, up from their previous target price of $77.00. Jefferies Group LLC’s price target points to a potential upside of 10.86% from the stock’s previous close.
A number of other equities research analysts have also recently weighed in on CL. Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Thursday, March 30th. Citigroup Inc. reissued a “neutral” rating and issued a $76.00 target price (up previously from $75.00) on shares of Colgate-Palmolive in a report on Friday, April 7th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Monday, April 24th. UBS AG reissued a “neutral” rating and issued a $78.00 target price (down previously from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. Finally, Vetr lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price on the stock. in a report on Wednesday, May 17th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have issued a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $75.82.
Colgate-Palmolive (NYSE:CL) traded down 0.41% during mid-day trading on Monday, reaching $71.26. 2,023,502 shares of the company’s stock traded hands. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The stock has a 50 day moving average of $72.84 and a 200 day moving average of $72.74. The company has a market cap of $62.77 billion, a P/E ratio of 26.48 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter in the previous year, the business earned $0.70 earnings per share. The firm’s revenue for the quarter was down .5% on a year-over-year basis. On average, equities research analysts predict that Colgate-Palmolive will post $2.89 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Colgate-Palmolive’s (NYSE:CL) Hold Rating Reaffirmed at Jefferies Group LLC” was posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/08/12/colgate-palmolives-nysecl-hold-rating-reaffirmed-at-jefferies-group-llc-updated-updated.html.
In other news, Vice Chairman Franck J. Moison sold 35,000 shares of the stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $71.52, for a total value of $2,503,200.00. Following the completion of the sale, the insider now owns 201,411 shares in the company, valued at $14,404,914.72. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Dennis J. Hickey sold 73,872 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $71.80, for a total value of $5,304,009.60. Following the completion of the sale, the chief financial officer now owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 203,969 shares of company stock worth $14,711,068. Company insiders own 1.02% of the company’s stock.
A number of large investors have recently modified their holdings of the stock. Chickasaw Capital Management LLC raised its stake in shares of Colgate-Palmolive by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock worth $1,238,000 after buying an additional 11,605 shares during the period. Meritage Portfolio Management raised its stake in shares of Colgate-Palmolive by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock worth $7,017,000 after buying an additional 255 shares during the period. Eastern Bank raised its stake in shares of Colgate-Palmolive by 0.8% in the first quarter. Eastern Bank now owns 10,939 shares of the company’s stock worth $801,000 after buying an additional 89 shares during the period. ProShare Advisors LLC raised its stake in shares of Colgate-Palmolive by 9.9% in the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock worth $64,382,000 after buying an additional 79,323 shares during the period. Finally, Lynch & Associates IN raised its stake in shares of Colgate-Palmolive by 4.1% in the first quarter. Lynch & Associates IN now owns 29,542 shares of the company’s stock worth $2,162,000 after buying an additional 1,175 shares during the period. Hedge funds and other institutional investors own 73.85% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
What are top analysts saying about Colgate-Palmolive Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive Company and related companies.